Moderna completes enrollment in large COVID-19 vaccine study

08:15 Sun, 04 June

GEO

USD

$ 2.6335

EUR

€ 2.8376

GBP

£ 3.3011

RUB

₽ 0.0325

TRY

₺ 0.0013

AZN

₼ 0.0155

XRP

0.5220

22.Oct .2020 22:00

Moderna completes enrollment in large COVID-19 vaccine study

449

Back

Moderna Inc said it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third of the participants from communities of color – Reuters reports.

Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273 – Reuters quotes the company.

The U.S. Food and Drug Administration requires at least two months of safety data after a full vaccination regime to review applications for emergency use authorization of an experimental vaccine.

Modern Medical Solution